Ignite Creation Date:
2024-05-06 @ 3:43 AM
Last Modification Date:
2024-10-26 @ 11:37 AM
Study NCT ID:
NCT02352571
Status:
UNKNOWN
Last Update Posted:
2016-07-06
First Post:
2015-01-21
Brief Title:
Safety Study of GC1118 Recombinant Human Anti-EGFR Antibody in Patients With Advanced Solid Cancer
Sponsor:
Green Cross Corporation
Organization:
GC Biopharma Corp
Organization Data
Organization:
GC Biopharma Corp
Class:
INDUSTRY
Study ID:
GC1118_P1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Green Cross Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None